REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Healthcare and pharma

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

1 2 3 4 5 19
India Pharma and Healthcare H1 FY2027 Half-Annual Update - Page 1
India Pharma and Healthcare H1 FY2027 Half-Annual Update EMIS Insights Industry Reports

Between March and September 2026, the Indian pharmaceutical and healthcare industries saw notable structural developments. Given the sector's strong growth prospects, foreign institutional capital flowed into the private hospital industry, which ...

View more details
USD 495 Date: November 2026 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2026 Q3 - Page 1
China Healthcare Sector Report 2026 Q3 EMIS Insights Industry Reports

China has the world's second-largest healthcare market. Its healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand ...

View more details
USD 995 Date: October 2026 Language: English
Format: PDF
Add to basket
Philippines Pharma and Healthcare Sector Report 2026-2027 - Page 1
Philippines Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

The Philippine healthcare system consists of both public and private components. Public healthcare is devolved to local government units; meanwhile, the central government operates a limited number of tertiary care and specialist health facilities. ...

View more details
USD 995 Date: August 2026 Language: English
Format: PDF
Add to basket
CEE Pharma and Healthcare Sector Report 2026-2027 - Page 1
CEE Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

The CEE healthcare and pharma sector sits at the intersection of two converging pressures: a population that is ageing and shrinking faster than its health systems are adapting, and a disease burden shaped by behavioural risk factors that have proven ...

View more details
USD 995 Date: August 2026 Language: English
Format: PDF
Add to basket
Poland Pharma and Healthcare Sector Report 2026-2027 - Page 1
Poland Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

Poland's healthcare and pharmaceutical sector is one of Central and Eastern Europe's largest and most dynamic markets, characterised by rapid transformation, substantial government investment, and structural financial challenges. Public healthcare ...

View more details
USD 995 Date: August 2026 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2026 Q2 - Page 1
China Healthcare Sector Report 2026 Q2 EMIS Insights Industry Reports

China has the world's second-largest healthcare market. Its healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand ...

View more details
USD 995 Date: July 2026 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2026 Q1 - Page 1
China Healthcare Sector Report 2026 Q1 EMIS Insights Industry Reports

China has the world's second-largest healthcare market. Its healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand ...

View more details
USD 995 Date: June 2026 Language: English
Format: PDF
Add to basket
ASEAN Pharma and Healthcare Sector Report 2026-2027 - Page 1
ASEAN Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

Southeast Asia is a subregion of the Asian continent which comprises eleven countries, notably Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor Leste, and Vietnam ...

View more details
USD 995 Date: May 2026 Language: English
Format: PDF
Add to basket
Indonesia Pharma and Healthcare Sector Report 2026-2027 - Page 1
Indonesia Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

Indonesia has one of the fastest-growing pharmaceutical and healthcare sectors in ASEAN. The Indonesian government launched a comprehensive national health insurance scheme in 2014 to ensure that all Indonesians have access to healthcare. Almost all ...

View more details
USD 995 Date: April 2026 Language: English
Format: PDF
Add to basket
India Pharma and Healthcare Sector Report 2026-2027 - Page 1
India Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

India's pharmaceutical and healthcare sector is globally recognised. India's reputation as the "pharmacy of the world" was established through its extensive production of generic medications and vaccines. For example, the Serum Institute of India, a ...

View more details
USD 995 Date: February 2026 Language: English
Format: PDF
Add to basket
1 2 3 4 5 19